Exchange: NASDAQ·Updated 07:30 PM EST
RNA logo

RNA Atrium Therapeutics Inc.

$6.52
$1.08
(14.38%)
Today
Closed $6.43
$0.09
(1.40%)
After Hours
Reported EarningsNov 12
Mkt Cap$162M
Vol337,583.00

About RNA

Atrium Therapeutics, Inc. operates as a biopharmaceutical company that provides RNA therapeutics services to the heart to transform the standard of care for people living with cardiomyopathies. Its products pipeline includes two lead development candidates: ATR 1072 for PRKAG2 syndrome and ATR 1086 for PLN cardiomyopathy, both conditions are severe, life-threatening, rare autosomal dominant progressive cardiomyopathies with no approved treatment options and high unmet need. The company was founded on September 30, 2025 and is headquartered in San Diego, CA.
51

Neutral Sentiment

How do you feel about RNA?

AIALuckyDog
$RNA This is lagging, but I see 400k+ in volume, as I saw last week when volume near $1M. It’s almost like they’re doing test runs🍿
focafoca99
$RNA urged its board to launch a strategic review, curb cash spending and explain the recent dilutive financing.

Advertisement|Remove ads.